BioCryst

$10.90
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.34 (-11.35%) Today

+$0.43 (+4.11%) As of 1:32 PM UTC after-hours

Why Robinhood?

You can buy or sell BioCryst and other stocks, options, and ETFs commission-free!

About BCRX

BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. The listed name for BCRX is BioCryst Pharmaceuticals, Inc. Common Stock.

CEO

Jon P. Stonehouse

Employees

140

Headquarters

Durham, North Carolina

Founded

1986

Market Cap

1.74B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

7.40M

High Today

$11.64

Low Today

$10.37

Open Price

$11.07

Volume

7.84M

52 Week High

$12.90

52 Week Low

$1.58

Analyst Ratings

80%

of 10 ratings

Buy

80%

Hold

20%

Sell

BCRX Earnings

-$0.34

-$0.23

-$0.11

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

-$0.25 per share

Actual

-$0.34 per share

Replay Earnings Call